共 21 条
- [1] Protective effect of Danhong injection in patients with acute myocardial infarction at a high risk of no-reflow during primary percutaneous coronary intervention[J]. Qi YOU,Jing WANG,Wei DONG,Feng TIAN,Hong-Xu LIU,Jing JING,Yun-Dai CHEN.Journal of Geriatric Cardiology. 2019 (05)
- [2] A New Perspective for Chinese Medicine Intervention for Coronary Artery Disease: Targeting Inflammation[J]. LI Si-ming,LI Jin-gen,XU Hao.Chinese Journal of Integrative Medicine. 2019(01)
- [5] Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention[J] . Fabio Mangiacapra,Edoardo Bressi,Giuseppe Di Gioia,Mariano Pellicano,Luigi Di Serafino,Aaron J. Peace,Jozef Bartunek,Carmine Morisco,William Wijns,Bernard De Bruyne,Emanuele Barbato.International Journal of Cardiology . 2020 (prep)
- [6] Danhong injection enhances angiogenesis after myocardial infarction by activating MiR-126/ERK/VEGF pathway[J] . Si-Nai Li,Ping Li,Wei-Hong Liu,Ju-Ju Shang,Sheng-Lei Qiu,Ming-Xue Zhou,Hong-Xu Liu.Biomedicine & Pharmacotherapy . 2019 (C)
- [7] Coronary microembolization and microvascular dysfunction[J] . Gerd Heusch,Andreas Skyschally,Petra Kleinbongard.International Journal of Cardiology . 2018
- [10] Relation Between Neutrophil-to-Lymphocyte Ratio and Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (09): : 1323 - 1328